Gemfibrozil

CAS No. 25812-30-0

Gemfibrozil( CI-719 | Lopid )

Catalog No. M13780 CAS No. 25812-30-0

Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 27 In Stock
50MG 34 In Stock
100MG 45 In Stock
200MG 57 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gemfibrozil
  • Note
    Research use only, not for human use.
  • Brief Description
    Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.
  • Description
    Gemfibrozil (Lopid) is an oral drug used to lower lipid levels. It belongs to a group of drugs known as fibrates. Increases activity of Peroxisome proliferator-activated receptor-alpha (PPARα) 'transcription factor ligand' , a receptor that is involved in metabolism of carbohydrates and fats, as well as adipose tissue differentiation. This increase in the synthesis of lipoprotein lipase thereby increases the clearance of triglycerides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CI-719 | Lopid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    25812-30-0
  • Formula Weight
    250.33
  • Molecular Formula
    C15H22O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 50 mg/mL (199.73 mM); DMSO: 50 mg/mL (199.73 mM)
  • SMILES
    CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
  • Chemical Name
    5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Clavey V, et al. Cell Physiol Biochem. 1999;9(3):139-49.
molnova catalog
related products
  • (±)4-HDHA

    (±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.

  • Balaglitazone

    Balaglitazone is a selective peroxisome proliferator-activated receptor (PPARγ) partial agonist with an EC50 value of 1.351 μM for human PPARγ.

  • Siramesine

    Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.